The association between ERBB2 (Erb-B2 Receptor Tyrosine Kinase 2) and Glioma Susceptibility 1 is well established and manually curated, with its 3 contributing sources — 2 of them expert-curated — recording a known molecular basis and pathogenic variants.
Sources3
Clinical variants38
Symptoms9
Compounds0
Trials0
Publications1
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.